Skip to content

Multicenter Stratified Randomized Crossover Controlled Trial of Continuous Positive Airway Pressure Therapy for OSAHS Patients in Plain and Plateau Areas

Study on Digital-Intelligent Management of High-Altitude Obstructive Sleep Apnea Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112890
Enrollment
Unknown
Registered
2025-11-20
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea-Hypopnea Syndrome

Interventions

lowland--Population with OSAHS:Phase A: Single-night continuous positive airway pressure (CPAP) therapy. A standard fixed-pressure CPAP device is used, equipped with a heated humidifier and an oronas
highland--Population with OSAHS:Phase A: Single-night continuous positive airway pressure (CPAP) therapy. A standard fixed-pressure CPAP device is used, equipped with a heated humidifier and an orona

Sponsors

Diqing Tibetan Autonomous Prefecture People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Adults aged >= 35 years, who meet the following criteria: 2.Suspected of having OSAHS (clinical manifestations are consistent with OSAHS symptoms, such as snoring, daytime sleepiness, etc., and/or preliminary screening indicates a high risk); 3.Confirmed diagnosis of OSAHS via overnight polysomnography (PSG) monitoring (apnea-hypopnea index [AHI] >= 5 events/hour), or those with no significant abnormalities on PSG (AHI < 5) may be included in the healthy control group (cohort); 4.Voluntarily participate in this study, understand the research procedures, and have signed a written informed consent form.

Exclusion criteria

Exclusion criteria: Participants who meet any of the following criteria will be excluded from the study: 1.Those unable to ensure a stable sleeping environment (e.g., frequent business trips due to work, or inconsistent nighttime sleeping locations); 2.Those with comorbid severe mental illnesses (e.g., bipolar disorder, schizophrenia, etc.) that affect compliance; 3.Those with active infectious diseases (e.g., tuberculosis, AIDS, syphilis, etc.); 4.Pregnant women; 5.Any other conditions deemed inappropriate for participation in this study by the researchers (e.g., severe physical illnesses that pose risks to intervention).

Design outcomes

Primary

MeasureTime frame
Apnea-Hypopnea Index per Hour;

Secondary

MeasureTime frame
Epworth Sleepiness Scale (ESS) Score;Pittsburgh Sleep Quality Index (PSQI);C-Reactive Protein (CRP) Level;

Countries

China

Contacts

Public ContactJiaming He

Diqing Tibetan Autonomous Prefecture People's Hospital

cmu000731@163.com+86 181 2126 3213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026